What's breaking now, across thousands of outlets.
Roche has scrapped development of a muscle-building drug, ending a trial testing the experimental medicine in combination with an anti-obesity injectable. The Swiss pharma is stopping work on emugrobart, aptly named GYM329, and is returning ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
COVID-19 vaccine maker BioNTech is to close three sites in Germany after efforts to find buyers failed. Meanwhile, Rhine water levels have fallen to record lows after an unusually dry September.
COVID-19 vaccine maker BioNTech is to close three sites in Germany after efforts to find buyers failed. Meanwhile, Rhine water levels have fallen to record lows after an unusually dry September.
Residents across the Malaga, Axarquia and Granada province will be able to get their free flu and Covid vaccinations this […]
Cara Delevingne makes an appearance too
Pharmacists say that due to a current shortage of flu vaccine supplies, they are restricting private immunisation to those over 65.
